Trademark: REFOLINEX
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for REFOLINEX
We do not have any records of a proof of use for REFOLINEX at this moment.
Possible trademark infringements of REFOLINEX
Basic Information about REFOLINEX
- Serial Number
- 98296074
- Filing Date
- 02 Dec 2023
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of REFOLINEX on the blockchain with WikiTrademarks.io.
- First use of REFOLINEX anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 003
- US Codes
- 001; 004; 006; 050; 051; 052
- First use of REFOLINEX anywhere
- No first use declared yet.
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
Who owns REFOLINEX?
1. Liptis Pharmaceuticals USA Inc. Spring Valley NY
Correspondent
- Michael J. Schwab Moritt Hock & Hamroff LLP
- 1407 Broadway
- Suite 3900
- New York, NY 10018
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io